Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression
<p><strong>Background</strong> Despite their revolutionary success in cancer treatment over the last decades, immunotherapies encounter limitations in certain tumor types and patients. The efficacy of immunotherapies depends on tumor antigen-specific CD8 T-cell viability and functi...
主要な著者: | Finisguerra, V, Dvorakova, T, Formenti, M, Van Meerbeeck, P, Mignion, L, Gallez, B, Van den Eynde, BJ |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
BMJ Publishing Group
2023
|
類似資料
-
Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression
著者:: Benoit J Van den Eynde, 等
出版事項: (2023-05-01) -
Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells
著者:: Dvorakova, T, 等
出版事項: (2024) -
Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
著者:: Zhu, J, 等
出版事項: (2017) -
Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
著者:: Jingjing Zhu, 等
出版事項: (2017-11-01) -
Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells
著者:: Tereza Dvorakova, 等
出版事項: (2024-09-01)